An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)

Clinical trial NCT02150928 · WITHDRAWN

Trial details

NCT number: NCT02150928
Sponsor: Jazz Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)

Start date: 2014-05-01
Primary completion: 2015-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.